{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T14:53:24Z","timestamp":1774796004585,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,11,4]],"date-time":"2012-11-04T00:00:00Z","timestamp":1351987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,11,4]],"date-time":"2012-11-04T00:00:00Z","timestamp":1351987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s15010-012-0349-z","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T09:25:33Z","timestamp":1351934733000},"page":"321-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii"],"prefix":"10.1007","volume":"41","author":[{"given":"M. H.","family":"Rigatto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. B.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Konzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P.","family":"Zavascki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,4]]},"reference":[{"issue":"Suppl 1","key":"349_CR1","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1086\/653051","volume":"51","author":"DE Craven","year":"2010","unstructured":"Craven DE, Hjalmarson KI. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box. Clin Infect Dis. 2010;51(Suppl 1):S59\u201366.","journal-title":"Clin Infect Dis"},{"key":"349_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American Thoracic Society","year":"2005","unstructured":"American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"key":"349_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1586\/eri.09.108","volume":"8","author":"AP Zavascki","year":"2010","unstructured":"Zavascki AP, Carvalhaes CG, Pic\u00e3o RC, Gales AC. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther. 2010;8:71\u201393.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"349_CR4","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/jac\/dkr239","volume":"66","author":"AC Gales","year":"2011","unstructured":"Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY antimicrobial surveillance program (2006\u201309). J Antimicrob Chemother. 2011;66:2070\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"349_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1473-3099(08)70133-6","volume":"8","author":"AP Zavascki","year":"2008","unstructured":"Zavascki AP, Li J. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria. Lancet Infect Dis. 2008;8:403\u20135.","journal-title":"Lancet Infect Dis"},{"key":"349_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/jac\/dkm357","volume":"60","author":"AP Zavascki","year":"2007","unstructured":"Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother. 2007;60:1206\u201315.","journal-title":"J Antimicrob Chemother"},{"key":"349_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/jac\/dkq390","volume":"66","author":"CH Kvitko","year":"2011","unstructured":"Kvitko CH, Rigatto MH, Moro AL, Zavascki AP. Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother. 2011;66:175\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"349_CR8","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/jac\/dkn128","volume":"61","author":"MS Oliveira","year":"2008","unstructured":"Oliveira MS, Prado GV, Costa SF, Grinbaum RS, Levin AS. Ampicillin\/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother. 2008;61:1369\u201375.","journal-title":"J Antimicrob Chemother"},{"key":"349_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/jac\/dkq069","volume":"65","author":"M Paul","year":"2010","unstructured":"Paul M, Bishara J, Levcovich A, Chowers M, Goldberg E, Singer P, et al. Effectiveness and safety of colistin: prospective comparative cohort study. J Antimicrob Chemother. 2010;65:1019\u201327.","journal-title":"J Antimicrob Chemother"},{"key":"349_CR10","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1086\/592577","volume":"47","author":"AP Zavascki","year":"2008","unstructured":"Zavascki AP, Goldani LZ, Cao G, Superti SV, Lutz L, Barth AL, et al. Pharmacokinetics of intravenous polymyxin B in critically ill patients. Clin Infect Dis. 2008;47:1298\u2013304.","journal-title":"Clin Infect Dis"},{"key":"349_CR11","unstructured":"Clinical Laboratory Standards Institute (CLSI) (2009) Performance standards for antimicrobial susceptibility testing; 19th informational supplement (M100-S19). Wayne, PA."},{"key":"349_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818\u201329.","journal-title":"Crit Care Med"},{"key":"349_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707\u201310.","journal-title":"Intensive Care Med"},{"key":"349_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"349_CR15","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","volume":"17","author":"O Zarkotou","year":"2011","unstructured":"Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17:1798\u2013803.","journal-title":"Clin Microbiol Infect"},{"key":"349_CR16","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/AAC.06268-11","volume":"56","author":"ZA Qureshi","year":"2012","unstructured":"Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56:2108\u201313.","journal-title":"Antimicrob Agents Chemother"},{"key":"349_CR17","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/jac\/dkq285","volume":"65","author":"LS Elias","year":"2010","unstructured":"Elias LS, Konzen D, Krebs JM, Zavascki AP. The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic. J Antimicrob Chemother. 2010;65:2231\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"349_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1164\/rccm.200802-239OC","volume":"178","author":"AA El Solh","year":"2008","unstructured":"El Solh AA, Akinnusi ME, Wiener-Kronish JP, Lynch SV, Pineda LA, Szarpa K. Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am J Respir Crit Care Med. 2008;178:513\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"349_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1179\/joc.2010.22.2.103","volume":"22","author":"S Kiem","year":"2010","unstructured":"Kiem S, Schentag JJ. Impact of organism species on microbial eradication and development of resistance in severe gram-negative pneumonia. J Chemother. 2010;22:103\u20139.","journal-title":"J Chemother"},{"key":"349_CR20","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1128\/JCM.01035-09","volume":"47","author":"AP Zavascki","year":"2009","unstructured":"Zavascki AP, Li J, Nation RL, Superti SV, Barth AL, Lutz L, et al. Stable polymyxin B susceptibility to Pseudomonas aeruginosa and Acinetobacter spp. despite persistent recovery of these organisms from respiratory secretions of patients with ventilator-associated pneumonia treated with this drug. J Clin Microbiol. 2009;47:3064\u20135.","journal-title":"J Clin Microbiol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-012-0349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-012-0349-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-012-0349-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-012-0349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:46:44Z","timestamp":1744170404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-012-0349-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1007\/s15010-012-0349-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,4]]},"assertion":[{"value":"3 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}